Pakistan Science Abstracts
Article details & metrics
No Detail Found!!
ALIVE Biofeedback for Insomnia: A Randomized Controlled Trial
Author(s):
1. Yusra Saleem: M.A.H.Q. Biological Research Centre, University of Karachi, Karachi, Pakistan; Department of Psychology, Malir University of Science and Technology, Karachi, Pakistan
2. Ujala Sajid: M.A.H.Q. Biological Research Centre, University of Karachi, Karachi, Pakistan; Department of Psychology, Malir University of Science and Technology, Karachi, Pakistan
3. Shamoon Noushad: Department of Psychology, Malir University of Science and Technology, Karachi, Pakistan
4. Sadaf Ahmed: M.A.H.Q. Biological Research Centre, University of Karachi, Karachi, Pakistan
Abstract:
Insomnia is a common sleep disorder that affects a large portion of the population. While there are several treatments available, such as medication and cognitive-behavioral therapy, some individuals may not respond well to these treatments. Biofeedback, a technique that provides individuals with real-time feedback on their physiological responses, has shown promise in treating insomnia. The aim of this study was to investigate the effectiveness of ALIVE biofeedback in treating insomnia. The study included 60 individuals aged = 18 years, who have been diagnosed with insomnia. Participants were randomly assigned to either an ALIVE biofeedback group or a control group. Participants in the ALIVE biofeedback group received six weekly sessions of biofeedback training using the ALIVE device. The ALIVE device measured physiological parameters, such as heart rate variability (HRV) and skin conductance and provided feedback to individuals through interactive games and relaxation exercises. Participants were taught relaxation techniques, such as deep breathing and progressive muscle relaxation, and received real-time feedback on their physiological responses. Participants in the control group received no treatment. The primary outcome measures were sleep quality, as measured by the Pittsburgh Sleep Quality Index (PSQI), and the Insomnia Severity Index (ISI). Secondary outcome measures included selfreported sleep latency, sleep duration, frequency of awakenings during the night, and sleep efficiency. Anxiety and depression symptoms were also measured using the Hospital Anxiety and Depression Scale (HADS). The assessments were performed at baseline, and after the six-week intervention. ALIVE biofeedback group displayed significant improvements in sleep quality compared to the control group. The participants in the ALIVE biofeedback group reported an increase in the duration of their sleep and a decrease in the frequency of sleep disturbances, such as waking up during the night. Additionally, the ALIVE biofeedback group reported feeling more rested and refreshed upon waking up in the morning. The control group, on the other hand, did not show significant improvements in their sleep quality. The participants in the control group reported similar sleep patterns and quality at the beginning and end of the study. The findings of this study have implications for the development of non-invasive and effective treatments for insomnia.
Page(s):
DOI: DOI not available
Published: Journal: Abstract Book on 9th Annual Neuroscience Conference (ANC-23) August 12-13, 2023 , Volume: 0, Issue: 0, Year: 2023
Keywords:
Keywords are not available for this article.
References:
References are not available for this document.
Citations
Citations are not available for this document.
0

Citations

0

Downloads

110

Views